Tag Archives: LLY

Top 10 Undervalued Stocks To Watch Right Now

If youre looking for an undervalued company in the auto segment thats almost guaranteed to grow slow and steady over the long term, then the Lear Corporation (LEA) should definitely be on your vetting list. The lowly PE ratio of 10 is merely the bitter aftertaste of investors in a company that went belly up during the great recession because of its debt pile. I believe the company has shaken off....More>>>

what is stock

Bull markets become trickiest to navigate just when they start to look easy. Lately, this one has been a breeze. Investors in U.S. stocks have gotten more than a years worth of gains in six months, with Standard & Poors 500-stock index returning 12.5% since last Novembers election, far ahead of the long-term annual average of 10%.

SEE ALSO: 5 Stocks to Buy Now

Moreover,....More>>>

best stock news

New Yorkers should avoid the area surrounding Trump Tower, Mayor Bill de Blasio said on Friday — not exactly the type of advice area businesses want to hear heading into the holiday season.

Donald Trump’s neighborhood in Midtown Manhattan has been flooded by cops, Secret Service agents and protesters along with the usual hordes of shoppers, tourists and office workers since his....More>>>

things to invest in now

What a difference one word makes. Cowen’s Doug Creutz and Stephen Glagola could have said that it’s not time to panic after Viacom (VIAB) said its negotiations with Dish Network (DISH) have been going nowhere. Instead, they inserted the word “necessarily,” changing the complexion of things. They explain:

Bloomberg News

Viacom shares are down several percent....More>>>

Best Casino Stocks To Buy For 2018

Related MPEL Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly Gaming Win Data Still A Viable Trading Opportunity? Macau posts best monthly revenue growth since early 2014 (Seeking Alpha) Related WYNN Macau Records Largest Monthly Revenue Growth In Nearly 3 Years Is Monthly....More>>>

Top 5 Performing Stocks To Buy For 2017

One of last week’s biggest winners wasGroupon (NASDAQ:GRPN), soaring 30.2% after posting strong quarterly results.Revenue clocked in at $934.9 million for the fourth quarter, up a mere 1.9% for the top dog in daily deals.

Checking in with less than 2% in top-line growth may not seem very impressive, but it’s all relative. Groupon’s been retreating out of poorly performing....More>>>

Here's Why Radius Health Gained as Much as 20.2% Today”

What happened

Shares of Radius Health (NASDAQ:RDUS) rose over 20% Monday morning after Amgen (NASDAQ:AMGN) announced worrisome complications were discovered during a phase 3 trial for its osteoporosis drug candidate, Evenity. While the drug candidate met its primary endpoint in a more than 4,000-patient phase 3 study, a high rate of serious heart-related side effects were discovered. The....More>>>

Top Gold Stocks To Watch For 2017

Roswell, GA, based Investment company Vident Investment Advisory, LLC buys SPDR S&P 500, Eaton Vance Tax-Advantaged Global Dividend Income , Calamos Strategic Total Return Fund, Calamos Convertible Opportunities and Income Fund, Liberty All-Star Equity Fund, Cohen & Steers Quality Income Realty Fund Inc, BlackRock Credit Allocation Income Trust, John Hancock Tax Advantaged Dividend Income....More>>>

Here's Why Radius Health Gained as Much as 20.2% Today”

What happened

Shares of Radius Health (NASDAQ:RDUS) rose over 20% Monday morning after Amgen (NASDAQ:AMGN) announced worrisome complications were discovered during a phase 3 trial for its osteoporosis drug candidate, Evenity. While the drug candidate met its primary endpoint in a more than 4,000-patient phase 3 study, a high rate of serious heart-related side effects were discovered. The....More>>>

Here's Why Radius Health Gained as Much as 20.2% Today”

What happened

Shares of Radius Health (NASDAQ:RDUS) rose over 20% Monday morning after Amgen (NASDAQ:AMGN) announced worrisome complications were discovered during a phase 3 trial for its osteoporosis drug candidate, Evenity. While the drug candidate met its primary endpoint in a more than 4,000-patient phase 3 study, a high rate of serious heart-related side effects were discovered. The....More>>>